FDA Commissioner Gottlieb Resigns - Washington Post, Citing Administration Official
Get Alerts MO Hot Sheet
Price: $71.68 +0.36%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.3%
Revenue Growth %: +1.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.3%
Revenue Growth %: +1.1%
Join SI Premium – FREE
(Updated - March 5, 2019 3:14 PM EST)
FDA Commissioner Scott Gottlieb resigned Tuesday, effective in about a month, according to the Washington Post, citing an administration official.
Tobacco names including Altria Group (NYSE: MO) climbed on the headline, while several biotech stocks including Vertex Pharma (NASDAQ: VRTX) declined.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Asahi Kasei's HOVILPRI for drug-resistant HSV
- FDA grants fast track status to Vir Biotechnology's prostate cancer drug
- FDA approves Genentech's Tecentriq for stage III colon cancer
Create E-mail Alert Related Categories
ETFs, FDA, Hot FDA News, Politics, Rumors, Trader TalkRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share